• Exchange: Sant. Comerc
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Biogen Idec Inc

+ Add to Watchlist


342.790 USD 0.0000.00%

As of 18:00:06 ET on 08/29/2014.

Snapshot for Biogen Idec Inc (BIIB)

Open: 342.790 Day's Range: 342.790 - 342.790 Volume: 0
Previous Close: 342.790 52wk Range: 221.360 - 351.530 1-Yr Rtn: +54.86%

Stock Chart for BIIB

No chart data available.
  • BIIB:CI 342.790
  • 1D
  • 1M
  • 1Y
Interactive BIIB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIIB

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 26.1632
Relative P/E vs. IPSA -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 13.1020
Est. PEG Ratio 1.3667
Market Cap (M USD) 80,948.04
Shares Outstanding (M) 236.14
30 Day Average Volume 53
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIIB

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BIIB

Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.

George A ScangosChief Executive OfficerSusan H AlexanderExec VP/Chief Legal Ofcr/Secy
Paul J ClancyExec VP:Finance/CFOStephen H Holtzman "Steve"Exec VP:Corporate Development
More Company Profile & Key Executives for BIIB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil